Skip to main content
Signal8

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology

$BRKRPress releaseJun 1, 2026, 7:00 AM ETRead the release

Bruker announced a suite of new mass spectrometry systems and software at ASMS, including the timsMRMS for ultra-high-resolution analysis and the timsOmni for top-down proteoform characterization. The company highlighted performance breakthroughs, such as identifying over 10,000 proteins per sample and achieving 4x sensitivity improvements for structural analysis.

Key figures

Order value
multi-million-dollar
Samples per day
500
Mass resolving power
1M to 10M
Sensitivity improvement
4x
Protein identification count
>10,000
Protein identification count high throughput
>6,500

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.